Skip to main content
. 2024 Dec 11;15:1478395. doi: 10.3389/fimmu.2024.1478395

Figure 3.

Figure 3

SOX13 mRNA levels in relation to clinical features and prognostic survival curve of THCA. (A) Relationship between SOX13 mRNA levels and T stage. (B) Links across SOX13 mRNA expression and pathologic stage. (C) Links across SOX13 mRNA levels and Histological type. (D) Links across SOX13 mRNA levels and Primary neoplasm focus type. (E) OS from the GEPIA database. (F) PFI from the GEPIA database. (G) The predictive performance of SOX13 (AUC). (H) Nomogram estimating the 1-, 3-, and 5-year OS of THCA patients. *P< 0.05, **P< 0.01.